Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

(MedPage Today) — Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis of federal survey data indicated…

Source link : https://www.medpagetoday.com/rheumatology/arthritis/118792

Author :

Publish date : 2025-12-02 19:01:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Related Posts

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

FDA Approves At-Home Device for Treatment-Resistant Depression

FDA Calls for New Warning on Flu Shots

Exercise vs Meds for Depression; Supplement’s Suicide Risk; Grants Terminated

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

FDA Approves At-Home Device for Treatment-Resistant Depression

FDA Calls for New Warning on Flu Shots

Exercise vs Meds for Depression; Supplement’s Suicide Risk; Grants Terminated

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Categories

Archives